The molecular and clinical characterization of this cohort confirms the gene-disease association of PTPN23 with a severe neurodevelopmental disorder characterized by developmental delay and structural brain abnormalities, and expands the range of clinical features that may be observed in patients with this novel rare genetic disorder. Here, PTPN23 is linked to Global developmental delay.